Browsing Articles by Author "Nurgozhin, T."

Now showing items 1-6 of 6

PHP185 A Situation Analysis Of Health Policy And Health Technology Assessment In Kazakhstan

Kostyuk, A.; Akanov, A.; Karp, L.; Nurgozhin, T.; Almadiyeva, A. (Value in Health, 2015-05-01)
PIN28 Comparative Effectiveness of Triple Therapy Versus Dual Therapy for Chronic Hepatitis C Virus Infection in Kazakhstan

Almadiyeva, A.; Kostyuk, A.; Nurgozhin, T. (Value in Health, 2013-11-01)

Currently, 23 thousand people (registered) are suffering from Hepatitis C in Germany (more 60% genotype 1). TThe licensing of direct-acting antivirals heralds a new era in the treatment of hepatitis C virus (HCV) genotype ...
PIN71 The Potential Public Health Benefit of Pneumococcal Conjugate Vaccines in Kazakhstan

Nurgozhin, T.; Yermekbaeva, B.; Topachevskyi, O. (Value in Health, 2012-11-01)

To evaluate cost–effectiveness of pneumococcal vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) compared with 13-valent pneumococcal conjugate vaccine (PCV-13) ...
PND1 Ivacaftor for Patients with Cystic Fibrosis: Clinical Efficacy and Cost-Effectiveness

Kostyuk, A.; Nurgozhin, T.; Akanov, A. (Value in Health, 2014-11-01)
Possible Changes of Pharmacokinetics of IL-2 Deposited in Red Blood Cells (RBC)

Tritek, V.; Zhaugasheva, S.K.; Gulyayev, A.; Sergazy, Sh.; Khassenbekova, Zh.; Yermekbayeva, B.; Nurgozhin, T. (Clinical Therapeutics, 2017-08-01)
Prevalence, awareness, treatment and control of arterial hypertension in Astana, Kazakhstan. A cross-sectional study

Supiyev, A.; Kossumov, A.; Utepova, L.; Nurgozhin, T.; Zhumadilov, Z.; Bobak, M. (Public Health, 2015-07-01)

Abstract ObjectiveVery little is known about prevalence of common cardiovascular risk factors in Central Asia. The aim of the study was to assess the prevalence, awareness, treatment and control of arterial hypertension, ...